FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

955351000168101: Tazocin EF 2 g/250 mg (piperacillin 2 g + tazobactam 250 mg) powder for injection, 2.25 g vial (trade product unit of use)

Status: current, Defined. Date: 30-Jun 2017. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
1954531000168119 Tazocin EF 2 g/250 mg (piperacillin 2 g + tazobactam 250 mg) powder for injection, 2.25 g vial (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
1954541000168111 Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial Is a trade product unit of use true Inferred relationship Some
Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial Is a piperacillin 2 g + tazobactam 250 mg injection, 2.25 g vial true Inferred relationship Some
Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial Is a Tazocin EF 2 g/250 mg true Inferred relationship Some
Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial has manufactured dose form powder for injection true Inferred relationship Some
Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial has unit of use vial true Inferred relationship Some 875690879
Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial has Australian BoSS tazobactam true Inferred relationship Some 288186750
Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial has intended active ingredient tazobactam true Inferred relationship Some 288186750
Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial has Australian BoSS piperacillin true Inferred relationship Some 875690878
Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial has intended active ingredient piperacillin true Inferred relationship Some 875690878
Inbound Relationships Type Active Source Characteristic Refinability Group
Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial has TPUU True Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial Inferred relationship Some 1
Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial has TPUU True Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start